Randomised comparative trial of the efficacy of paracetamol syrup and dispersible tablets for the treatment of fever in children
OBJECTIVE: Fever is the most common reason for the presentation of children in the outpatient department. Paracetamol is marketed in different formulations for ease of administration to the paediatric population. These include syrups, dispersible tablets and rectal inserts. Dispersible tablets disintegrate rapidly in liquid and are subsequently taken orally, providing another oral formulation. We determined if there is a difference in the antipyretic efficacy of the syrup and the dispersible formulation of paracetamol, thereby prompting the development of the latter (another oral formulation) for use in children.
METHODS: A randomised, controlled, double-blind intervention of a single dose of both formulations was given to febrile children, and their temperatures were documented twice in 30-minute intervals. Temperature changes were compared statistically.
RESULTS: The mean temperatures at recruitment were 38.2 ± 0.5°C and 38.3 ± 0.6°C for the dispersible and syrup group, respectively. There was no significant difference between the temperature changes at T2 (30 minutes) and T3 (60 minutes) between the two study arms. However, the temperature was significantly different at T1 (baseline), T2 and T3 within the dispersible and syrup groups.
CONCLUSION: The decreasing trend in temperature was similar in both groups. Both preparations produced statistically similar antipyretic effects with no reported adverse drug reaction.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
---|---|
Enthalten in: |
The Journal of international medical research - 49(2021), 3 vom: 18. März, Seite 300060521999755 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Okereke, Benjamin [VerfasserIn] |
---|
Links: |
---|
Themen: |
362O9ITL9D |
---|
Anmerkungen: |
Date Completed 14.05.2021 Date Revised 14.05.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1177/0300060521999755 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM322930383 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM322930383 | ||
003 | DE-627 | ||
005 | 20231225183102.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/0300060521999755 |2 doi | |
028 | 5 | 2 | |a pubmed24n1076.xml |
035 | |a (DE-627)NLM322930383 | ||
035 | |a (NLM)33736533 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Okereke, Benjamin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Randomised comparative trial of the efficacy of paracetamol syrup and dispersible tablets for the treatment of fever in children |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.05.2021 | ||
500 | |a Date Revised 14.05.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: Fever is the most common reason for the presentation of children in the outpatient department. Paracetamol is marketed in different formulations for ease of administration to the paediatric population. These include syrups, dispersible tablets and rectal inserts. Dispersible tablets disintegrate rapidly in liquid and are subsequently taken orally, providing another oral formulation. We determined if there is a difference in the antipyretic efficacy of the syrup and the dispersible formulation of paracetamol, thereby prompting the development of the latter (another oral formulation) for use in children | ||
520 | |a METHODS: A randomised, controlled, double-blind intervention of a single dose of both formulations was given to febrile children, and their temperatures were documented twice in 30-minute intervals. Temperature changes were compared statistically | ||
520 | |a RESULTS: The mean temperatures at recruitment were 38.2 ± 0.5°C and 38.3 ± 0.6°C for the dispersible and syrup group, respectively. There was no significant difference between the temperature changes at T2 (30 minutes) and T3 (60 minutes) between the two study arms. However, the temperature was significantly different at T1 (baseline), T2 and T3 within the dispersible and syrup groups | ||
520 | |a CONCLUSION: The decreasing trend in temperature was similar in both groups. Both preparations produced statistically similar antipyretic effects with no reported adverse drug reaction | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Paracetamol | |
650 | 4 | |a antipyretic | |
650 | 4 | |a dispersible | |
650 | 4 | |a fever | |
650 | 4 | |a paediatric | |
650 | 4 | |a syrup | |
650 | 7 | |a Antipyretics |2 NLM | |
650 | 7 | |a Tablets |2 NLM | |
650 | 7 | |a Acetaminophen |2 NLM | |
650 | 7 | |a 362O9ITL9D |2 NLM | |
700 | 1 | |a Ibeleme, Okezie |e verfasserin |4 aut | |
700 | 1 | |a Bisi-Onyemaechi, Adaobi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of international medical research |d 1973 |g 49(2021), 3 vom: 18. März, Seite 300060521999755 |w (DE-627)NLM000148504 |x 1473-2300 |7 nnns |
773 | 1 | 8 | |g volume:49 |g year:2021 |g number:3 |g day:18 |g month:03 |g pages:300060521999755 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/0300060521999755 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 49 |j 2021 |e 3 |b 18 |c 03 |h 300060521999755 |